SCA
SZYM

SAC Capital Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

SAC Capital Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-800,600
Closed -$9.29M – 1471
2014
Q1 		$9.29M Buy
800,600
+723,700
+941% +$8.52M 0.05% 422
2013
Q4 		$837K Sell
76,900
-127,400
-62% -$1.25M ﹤0.01% 978
2013
Q3 		$2.2M Buy
+204,300
New +$2.33M 0.01% 722

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SAC Capital Advisors's SZYM Position: Q2 2014 in Review

SAC Capital Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2014, closing a stake of 800,600 shares — an estimated $9.29M sold.

SAC Capital Advisors first reported a position in SZYM in Q3 2013 and held it in 3 quarters. The position peaked at $9.29M in Q1 2014. 124 funds tracked by Wall St. Rank hold SZYM as of Q2 2014.

  • SAC Capital Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 800,600 SOLAZYME INC COM STK (DE) shares in Q2 2014, an estimated $9.29M.
  • SAC Capital Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
  • SAC Capital Advisors's SOLAZYME INC COM STK (DE) position peaked at $9.29M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.